x min read

Market Movers: American Realty Capital Properties, Inc. (NASDAQ:ARCP), Amazon.com, Inc. (NASDAQ:AMZN), Cigna Corp. (NYSE:CI), Nektar Therapeutics (NASDAQ:NKTR), Franco-Nevada Corporation (NYSE:FNV)

Market Movers: American Realty Capital Properties, Inc. (NASDAQ:ARCP), Amazon.com, Inc. (NASDAQ:AMZN), Cigna Corp. (NYSE:CI), Nektar Therapeutics (NASDAQ:NKTR), Franco-Nevada Corporation (NYSE:FNV)
Written by
Charles Donlon
Published on
November 14, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

RCS Capital Seeks to Distance Itself From American Realty Capital Properties, Inc. (NASDAQ:ARCP), Nicholas Schorsch-Led Firm Defends Its Accounting, Internal Controls. American Realty Capital Properties, Inc. (NASDAQ:ARCP) belongs to Financial sector. Its net profit margin is -71.80% and weekly performance is 1.97%. On last trading day company shares ended up $8.81. American Realty Capital Properties, Inc. (NASDAQ:ARCP) distance from 50-day simple moving average (SMA50) is -22.49%. The long-running battle between Amazon.com, Inc. (NASDAQ:AMZN) and publisher Hachette has come to a close, after the companies reached agreement over online and ebook sales after months of acrimony that pitted the world’s largest online retailer against authors, agents and publishers. Amazon.com, Inc. (NASDAQ:AMZN) shares advanced 1.60% in last trading session and ended the day at $316.48. AMZN Gross Margin is 28.60% and its return on assets is -0.60%. Amazon.com, Inc. (NASDAQ:AMZN) quarterly performance is -5.14%. Zacks reissued their neutral rating on shares of CIGNA (NYSE:CI) in a research note released on Monday morning. They currently have a $104.00 target price on the stock. On 13 November, Cigna Corp. (NYSE:CI) shares advanced 0.59% and was closed at $102.71. CI EPS growth in last 5 year was 38.10%. Cigna Corp. (NYSE:CI) year to date (YTD) performance is 17.46%. On Nov. 6, Nektar Therapeutics (NASDAQ:NKTR) reported its financial results for the third quarter ended September 30, 2014. Cash and investments in marketable securities at September 30, 2014 were $261.6 million as compared to $301.4 million at June 30, 2014. Nektar Therapeutics (NASDAQ:NKTR) ended the last trading day at $13.86. Company weekly volatility is calculated as 4.69% and price to cash ratio as 6.38. Nektar Therapeutics (NASDAQ:NKTR) showed a weekly performance of 2.21%. On Nov. 5, Franco-Nevada Corporation (NYSE:FNV) reported third quarter 2014 results with 70,071 Gold Equivalent Ounces(1) ("GEOs") being earned, an increase of 23.6% over the third quarter of 2013. In addition, the Company recorded revenue of $107.6 million, Net Income of $33.2 million, or $0.22 per share, Adjusted Net Income(2) of $34.5 million, or $0.23 per share and Adjusted EBITDA(3) of $88.7 million, or $0.59 per share. Franco-Nevada Corporation (NYSE:FNV) shares moved down -1.74% in last trading session and ended the day at $50.18. Franco-Nevada Corporation (NYSE:FNV) quarterly performance is -13.47%.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.